| Tag | Content |
|---|
EnhancerAtlas ID | HS034-11111 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr16:27386190-27386860 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr16:27386564-27386575 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr16:27386624-27386639 | AAACTGACCAATGAG | + | 6.2 | | Stat6 | MA0520.1 | chr16:27386486-27386501 | CAGTTCCAGAGAACT | + | 7.07 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09427 | chr16:27384545-27387300 | CD14 | | SE_17448 | chr16:27383584-27387027 | CD4p_CD25-_CD45RAp_Naive | | SE_18369 | chr16:27385023-27386916 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_32588 | chr16:27383754-27387820 | GM12878 | | SE_58873 | chr16:27377779-27444663 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I027372 | chr16 | 27383747 | 27387314 |
|
Enhancer Sequence | TTTGTACCTG GCCCTGGTTC AAAGTGAGAA GTGAGGCTTC TCATGTCTTC AGACACATGA 60
CCTGACCCCT CTAGACACCA TCATCTGACT ACACGCCACC ACCCAGCCAC AGTTCCCAGC 120
CCACACCATG CAATTTCAAC CTCCAAGCCT TTTCTCATGC CTTTCCCTCT GGCAGGCACG 180
CCCCTCCCTA CCACTCTTCC GGACGAACCC GGCTATCCTG CCTGCCCTGT ATCTACTCTC 240
CCTTCTTCTG ACATCACCAC CTGGTGGTCC TTGCCGGGAC AGCGTCTTCC CACTCGCAGT 300
TCCAGAGAAC TGATCTAACT GCCAGAGAAC TGATCTAACT CCTAGCTTTC CAACAGGGCA 360
CATGACTCAG GCTTGGCCAA TCAGAGCATT CCTTTCCCAA TCTGAAGATT GGTTCAGGGA 420
CAGGCATATG ATTAAAACTG ACCAATGAGA GCTTTTCCTG GTAGCATCAT TGGAACCATT 480
AGGAAAACAT GCCTTCTTTC CTTTGGGCTT TGAAAGCTGG TAGGTGGTAG GTCTTGGCTT 540
CTGAGGTCCC TGCTTTTCTT TGGCCACCAA TGAGGCTTCC TCAGCTTGCT TGAGAATGAG 600
ACTAAAGCCA ATACAAAAGA AAGCAGATCC CAGAGTAGAA CCTTCCAACC TGAAGAAATT 660
ATTTGAGAAC 670
|
